. Freeman-Cook K, et al.Cancer Cell. 2021 Sep 11:S1535-6108(21)00449-9. doi: 10.1016/j.ccell.2021.08.009. Online ahead of print.Cancer Cell. 2021.PMID: 34520734.
.
Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.
Gadani SP, Reyes-Mantilla M, Jank L, Harris S, Douglas M, Smith MD, Calabresi PA, Mowry EM, Fitzgerald KC, Bhargava P.. Parkinson Study Group SURE-PD3 Investigators, et al.JAMA. 2021 Sep 14;326(10):926-939. doi: 10.1001/jama.2021.10207.JAMA. 2021.PMID: 34519802.
.
. DeVito LM, et al.Ann N Y Acad Sci. 2021 Sep 8. doi: 10.1111/nyas.14681. Online ahead of print.Ann N Y Acad Sci. 2021.PMID: 34498278.
SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project.
Ferreiro-Iglesias R, Hernández-Camba A, Serrano Labajos R, Rodríguez-Lago I, Zabana Y, Barreiro-de Acosta M; Young Group of Geteccu, ACCU Spain.
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
